Logo

Amoy Diagnostics

Amoy Diagnostics PLC Panel Gets Approval in Japan as CDx for Retevmo in Non-Small Cell Lung Cancer

Oncologists in Japan can now use the AmoyDx Pan Lung Cancer PCR Panel to identify patients with RET fusions that make them eligible for treatment with the Eli Lilly drug.

Alercell to Distribute Amoy Diagnostic Ros1 Gene Fusion Detection Kit in US

The 14-fusion PCR assay for lung cancer subtyping is available for research-use only but will be more broadly distributed when the kits gain FDA clearance.

AmoyDx, Beckman Coulter to Develop Applications for NGS Library Prep Instrument

The Chinese diagnostic company will develop applications specifically designed for Beckman Coulter's forthcoming automated NGS library prep liquid handler.

Amoy Diagnostics, Pierre Fabre Collaborate to Develop CDx in China

The companion diagnostic kits will support marketing authorization applications for Pfizer's Braftovi and Mektovi.

New Products Posted to GenomeWeb: Amoy Diagnostics, Akoya Biosciences, Congenica, Lucence

Aug 19, 2021

Amoy Diagnostics, Amgen Partner on Lung Cancer CDx Development for Lumakras in Japan

Aug 17, 2021

Amoy Diagnostics CDx Gets Japanese Approval to ID NSCLC Patients Eligible for Tepmetko

Jun 30, 2021

AmoyDx PCR Panel Receives Japanese Approval as CDx for Non-Small Cell Lung Cancer Therapies

Feb 19, 2021

AmoyDx, AstraZeneca Strike Ovarian Cancer Companion Diagnostic Alliance

Dec 23, 2020

Amoy Diagnostics, Merck KGaA Partner for Lung Cancer Companion Diagnostic Development in China

Aug 27, 2020

Amoy Diagnostics, Haihe Pharmaceutical Ink Agreement to Codevelop CDx for Lung Cancer Treatment

Aug 20, 2020

AmoyDx Strikes CDx Development Deal for Merck KGaA Cancer Drug

Mar 25, 2020

AmoyDx, Janssen Research and Development Partner on NGS-Based Companion Diagnostic

Jan 3, 2020

Massachusetts Startup Focuses on Long-Read Sequencing Technology
Premium

Nov 25, 2019

AmoyDx, Eisai Form CDx Development Alliance

Oct 4, 2019

In Brief This Week: Thermo Fisher, HalioDx, OncoCyte, Amoy Diagnostics, More

Jun 24, 2019

AmoyDx, Premia Partner With Loxo on Genetic Testing for Cancer Therapy

Mar 1, 2019

AmoyDx Wins Chinese Regulatory Approval for BRCA Mutation Test

Jan 29, 2019

AmoyDx, Sanomics Ink Deal for Multigene Mutation Detection Kit

Oct 12, 2018

AmoyDx Lung Cancer CDx Approved in South Korea

Jan 29, 2018

AmoyDx, Medikonia Ink MDx Distribution Deal

Jan 22, 2018

AmoyDx Wins Chinese Approval for Lung Cancer Liquid Biopsy CDx

May 16, 2017

Amoy Dx Partners With Canbridge on CDx Development

Feb 3, 2017

Japan Regulators Approve AmoyDx's Lung Cancer CDx

Jul 28, 2016

Merck KGaA, AmoyDx Partner on Colorectal Cancer Test for Chinese Market

Breaking News
The Scan

Cell Signaling Pathway Identified as Metastasis Suppressor

A new study in Nature homes in on the STING pathway as a suppressor of metastasis in a mouse model of lung cancer.

Using Bees to Gain Insights into Urban Microbiomes

As bees buzz around, they pick up debris that provides insight into the metagenome of their surroundings, researchers report in Environmental Microbiome.

Age, Genetic Risk Tied to Blood Lipid Changes in New Study

A study appearing in JAMA Network Open suggests strategies to address high lipid levels should focus on individuals with high genetic risk and at specific ages.

Study Examines Insights Gained by Adjunct Trio RNA Sequencing in Complex Pediatric Disease Cases

Researchers in AJHG explore the diagnostic utility of adding parent-child RNA-seq to genome sequencing in dozens of families with complex, undiagnosed genetic disease.